28.89
+1.62(+5.94%)
Currency In USD
| Previous Close | 27.27 |
| Open | 29.66 |
| Day High | 29.1 |
| Day Low | 27.84 |
| 52-Week High | 42.29 |
| 52-Week Low | 23.23 |
| Volume | 547,667 |
| Average Volume | 394,132 |
| Market Cap | 928.29M |
| PE | 15.53 |
| EPS | 1.86 |
| Moving Average 50 Days | 28.25 |
| Moving Average 200 Days | 32.46 |
| Change | 1.62 |
If you invested $1000 in Collegium Pharmaceutical, Inc. (COLL) 10 years ago, it would be worth $2,274.8 as of May 11, 2025 at a share price of $28.89. Whereas If you bought $1000 worth of Collegium Pharmaceutical, Inc. (COLL) shares 5 years ago, it would be worth $1,341.85 as of May 11, 2025 at a share price of $28.89.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Collegium to Report First Quarter 2025 Financial Results on May 8, 2025
GlobeNewswire Inc.
Apr 24, 2025 12:00 PM GMT
STOUGHTON, Mass., April 24, 2025 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced that it will report first quarter 2025 financial results after the market closes on Thursday, May 8, 2025. Following the release of t
Collegium to Participate in 24th Annual Needham Virtual Healthcare Conference
GlobeNewswire Inc.
Apr 01, 2025 12:00 PM GMT
STOUGHTON, Mass., April 01, 2025 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced that management will participate in a fireside chat at the 24th Annual Needham Healthcare Conference being held virtually from April
Collegium Announces Updates to its Board of Directors and Executive Leadership Team
GlobeNewswire Inc.
Mar 17, 2025 11:00 AM GMT
– Gino Santini Appointed as Chairman of the Board, Michael Heffernan, Founder and Chairman and Gwen A. Melincoff, Board Member to Retire from Board – – Dr. Carlos Paya Nominated to Board of Directors – – New Executives Appointed to Leadership